Cetera Investment Advisers Has $14.87 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Cetera Investment Advisers trimmed its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.9% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 160,405 shares of the exchange traded fund’s stock after selling 4,815 shares during the quarter. Cetera Investment Advisers owned about 0.21% of SPDR S&P Biotech ETF worth $14,871,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. HBK Sorce Advisory LLC raised its holdings in SPDR S&P Biotech ETF by 2.6% during the 1st quarter. HBK Sorce Advisory LLC now owns 4,538 shares of the exchange traded fund’s stock worth $431,000 after purchasing an additional 113 shares during the last quarter. Intellectus Partners LLC grew its holdings in SPDR S&P Biotech ETF by 1.0% during the 2nd quarter. Intellectus Partners LLC now owns 11,334 shares of the exchange traded fund’s stock worth $1,051,000 after acquiring an additional 113 shares during the period. Pacific Center for Financial Services raised its position in shares of SPDR S&P Biotech ETF by 2.8% during the 1st quarter. Pacific Center for Financial Services now owns 4,359 shares of the exchange traded fund’s stock valued at $414,000 after acquiring an additional 118 shares during the last quarter. Kingsview Wealth Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 3.8% in the 1st quarter. Kingsview Wealth Management LLC now owns 3,495 shares of the exchange traded fund’s stock worth $332,000 after purchasing an additional 127 shares during the last quarter. Finally, Bourgeon Capital Management LLC grew its stake in shares of SPDR S&P Biotech ETF by 5.9% during the second quarter. Bourgeon Capital Management LLC now owns 2,427 shares of the exchange traded fund’s stock worth $225,000 after purchasing an additional 135 shares during the period.

SPDR S&P Biotech ETF Trading Up 0.9 %

NYSEARCA XBI opened at $97.51 on Friday. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The company has a market capitalization of $7.43 billion, a PE ratio of 11.47 and a beta of 1.11. The stock has a 50-day simple moving average of $98.80 and a 200 day simple moving average of $94.03.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.